Dr. James Conway is a Professor of Pediatrics at the University of Wisconsin-Madison School of Medicine & Public Health in the Divisions of Infectious Diseases & Global Pediatrics. He serves as Pediatric Infectious Diseases Fellowship Program Director and Medical Director for UW Health Immunization Programs, as well as Director of the SMPH Office of Global Health. He is responsible for coordinating global health educational programs involving health professional students at UW-Madison, and oversight of international programs in the UW School of Medicine & Public Health through the Dept. of Academic Affairs. He previously served as the Associate Director for Health Sciences in the UW Global Health Institute from 2011-2022 and is now a member of the GHI Advisory Committee.
Dr. Conway has spent much of his career working to improve immunization systems and address vaccine hesitancy in the US and abroad. He is a Fellow of the American Academy of Pediatrics, where he serves as a Global Sustainability advisor, and received an AAP Special Achievement Award in 2009 for his global immunization projects and another in 2016 for HPV advocacy. He is a member of the Pediatric Infectious Disease Society Vaccine Advocacy Committee and has served on the American Board of Pediatrics – Pediatric Infectious Diseases Sub Board since 2018, and is now Chair for 2022-4.
He has been engaged in a longitudinal project spanning nearly a decade as a Technical and Global Sustainability Advisor for a collaborative program between the American Academy of Pediatrics and the Centers for Disease Control, working to simultaneously strengthen pediatric professional societies and immunization programs in over a dozen high priority countries in Africa & Asia.
He has served on the UW System & UW-Madison Emergency Operations Committees as well as the State Disaster Medical Advisory Committee on COVID-19 vaccines since early in the pandemic. He also has been a scientific advisor to pharmaceutical, healthcare and public health organizations regionally and internationally, including most recently working on an array of COVID-19 vaccine development projects.
